Exact Mass: 563.3108

Exact Mass Matches: 563.3108

Found 133 metabolites which its exact mass value is equals to given mass value 563.3108, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Fosinopril

(2S,4S)-4-cyclohexyl-1-[2-[[(1S)-2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphoryl]-1-oxoethyl]-2-pyrrolidinecarboxylic acid

C30H46NO7P (563.3012)


Fosinopril is a phosphinic acid-containing ester prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is rapidly hydrolyzed to fosinoprilat, its principle active metabolite. Fosinoprilat inhibits ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Fosinopril may be used to treat mild to moderate hypertension, as an adjunct in the treatment of congestive heart failure, and to slow the rate of progression of renal disease in hypertensive individuals with diabetes mellitus and microalbuminuria or overt nephropathy. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3324

   

Dihydroergocornine

N-[2-hydroxy-5,8-dioxo-4,7-bis(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraene-4-carboxamide

C31H41N5O5 (563.3108)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

Fosenopril

4-cyclohexyl-1-(2-{[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)pyrrolidine-2-carboxylic acid

C30H46NO7P (563.3012)


   

Deoxytalopiericidin A1

Deoxytalopiericidin A1

C30H45NO9 (563.3094)


   

Phe Ile Arg Glu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]pentanedioic acid

C26H41N7O7 (563.3067)


   

Phe Glu Ile Arg

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-carboxybutanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C26H41N7O7 (563.3067)


   

Asn Arg Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]hexanoic acid

C25H41N9O6 (563.318)


   

Asp Leu Phe Arg

Asp Leu Phe Arg

C26H41N7O7 (563.3067)


   

fosinopril

(2S,4S)-4-cyclohexyl-1-[2-[[(1S)-2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphoryl]-1-oxoethyl]-2-pyrrolidinecarboxylic acid

C30H46NO7P (563.3012)


C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE standard compound; INTERNAL_ID 2247

   

Glu Phe Ile Arg

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-phenylpropanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C26H41N7O7 (563.3067)


   

Glu Phe Leu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-phenylpropanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C26H41N7O7 (563.3067)


   

Glu Phe Arg Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C26H41N7O7 (563.3067)


   

Glu Phe Arg Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C26H41N7O7 (563.3067)


   

Glu Ile Phe Arg

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-methylpentanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C26H41N7O7 (563.3067)


   

Glu Ile Arg Phe

(4S)-4-amino-4-{[(1S,2S)-1-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butyl]carbamoyl}-2-methylbutyl]carbamoyl}butanoic acid

C26H41N7O7 (563.3067)


   

Glu Leu Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-methylpentanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C26H41N7O7 (563.3067)


   

Glu Leu Arg Phe

(4S)-4-amino-4-{[(1S)-1-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butyl]carbamoyl}-3-methylbutyl]carbamoyl}butanoic acid

C26H41N7O7 (563.3067)


   

Glu Arg Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C26H41N7O7 (563.3067)


   

Glu Arg Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C26H41N7O7 (563.3067)


   

Glu Arg Ile Phe

(4S)-4-amino-4-{[(1S)-4-carbamimidamido-1-{[(1S,2S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-methylbutyl]carbamoyl}butyl]carbamoyl}butanoic acid

C26H41N7O7 (563.3067)


   

Glu Arg Leu Phe

(4S)-4-amino-4-{[(1S)-4-carbamimidamido-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-3-methylbutyl]carbamoyl}butyl]carbamoyl}butanoic acid

C26H41N7O7 (563.3067)


   

Phe Glu Leu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-carboxybutanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C26H41N7O7 (563.3067)


   

Phe Glu Arg Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-carboxybutanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C26H41N7O7 (563.3067)


   

Phe Glu Arg Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-carboxybutanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C26H41N7O7 (563.3067)


   

Phe Ile Glu Arg

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-4-carboxybutanamido]-5-carbamimidamidopentanoic acid

C26H41N7O7 (563.3067)


   

Phe Ile Val Trp

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Phe Ile Trp Val

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Phe Lys Asn Arg

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-3-carbamoylpropanamido]-5-carbamimidamidopentanoic acid

C25H41N9O6 (563.318)


   

Phe Lys Arg Asn

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-5-carbamimidamidopentanamido]-3-carbamoylpropanoic acid

C25H41N9O6 (563.318)


   

Phe Leu Glu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-4-carboxybutanamido]-5-carbamimidamidopentanoic acid

C26H41N7O7 (563.3067)


   

Phe Leu Arg Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]pentanedioic acid

C26H41N7O7 (563.3067)


   

Phe Leu Val Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Phe Leu Trp Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Phe Asn Lys Arg

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carbamoylpropanamido]hexanamido]-5-carbamimidamidopentanoic acid

C25H41N9O6 (563.318)


   

Phe Asn Arg Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carbamoylpropanamido]-5-carbamimidamidopentanamido]hexanoic acid

C25H41N9O6 (563.318)


   

Phe Arg Glu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-4-carboxybutanamido]-3-methylpentanoic acid

C26H41N7O7 (563.3067)


   

Phe Arg Glu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-4-carboxybutanamido]-4-methylpentanoic acid

C26H41N7O7 (563.3067)


   

Phe Arg Ile Glu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]pentanedioic acid

C26H41N7O7 (563.3067)


   

Phe Arg Lys Asn

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]hexanamido]-3-carbamoylpropanoic acid

C25H41N9O6 (563.318)


   

Phe Arg Leu Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]pentanedioic acid

C26H41N7O7 (563.3067)


   

Phe Arg Asn Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-carbamoylpropanamido]hexanoic acid

C25H41N9O6 (563.318)


   

Phe Val Ile Trp

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Phe Val Leu Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Phe Val Trp Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Phe Val Trp Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Phe Trp Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Phe Trp Leu Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Phe Trp Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-3-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Phe Trp Val Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-4-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Ile Glu Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-carboxybutanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C26H41N7O7 (563.3067)


   

Ile Glu Arg Phe

(4S)-4-[(2S,3S)-2-amino-3-methylpentanamido]-4-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butyl]carbamoyl}butanoic acid

C26H41N7O7 (563.3067)


   

Ile Phe Glu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-4-carboxybutanamido]-5-carbamimidamidopentanoic acid

C26H41N7O7 (563.3067)


   

Ile Phe Arg Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]pentanedioic acid

C26H41N7O7 (563.3067)


   

Ile Phe Val Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Ile Phe Trp Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Ile Arg Glu Phe

(4S)-4-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-4-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butanoic acid

C26H41N7O7 (563.3067)


   

Ile Arg Phe Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]pentanedioic acid

C26H41N7O7 (563.3067)


   

Ile Val Phe Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Ile Val Trp Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Ile Trp Phe Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Ile Trp Val Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Lys Phe Asn Arg

(2S)-5-carbamimidamido-2-[(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]propanamido]pentanoic acid

C25H41N9O6 (563.318)


   

Lys Phe Arg Asn

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]pentanamido]-3-carbamoylpropanoic acid

C25H41N9O6 (563.318)


   

Lys Asn Phe Arg

(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-phenylpropanamido]pentanoic acid

C25H41N9O6 (563.318)


   

Lys Asn Arg Phe

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-3-carbamoyl-2-[(2S)-2,6-diaminohexanamido]propanamido]pentanamido]-3-phenylpropanoic acid

C25H41N9O6 (563.318)


   

Lys Arg Phe Asn

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-2,6-diaminohexanamido]pentanamido]-3-phenylpropanamido]-3-carbamoylpropanoic acid

C25H41N9O6 (563.318)


   

Lys Arg Asn Phe

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-2,6-diaminohexanamido]pentanamido]-3-carbamoylpropanamido]-3-phenylpropanoic acid

C25H41N9O6 (563.318)


   

Leu Glu Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-carboxybutanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C26H41N7O7 (563.3067)


   

Leu Glu Arg Phe

(4S)-4-[(2S)-2-amino-4-methylpentanamido]-4-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butyl]carbamoyl}butanoic acid

C26H41N7O7 (563.3067)


   

Leu Phe Glu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-4-carboxybutanamido]-5-carbamimidamidopentanoic acid

C26H41N7O7 (563.3067)


   

Leu Phe Arg Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]pentanedioic acid

C26H41N7O7 (563.3067)


   

Leu Phe Val Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Leu Phe Trp Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Leu Arg Glu Phe

(4S)-4-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-4-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butanoic acid

C26H41N7O7 (563.3067)


   

Leu Arg Phe Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]pentanedioic acid

C26H41N7O7 (563.3067)


   

Leu Val Phe Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Leu Val Trp Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Leu Trp Phe Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Leu Trp Val Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Asn Phe Lys Arg

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-phenylpropanamido]hexanamido]-5-carbamimidamidopentanoic acid

C25H41N9O6 (563.318)


   

Asn Phe Arg Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]hexanoic acid

C25H41N9O6 (563.318)


   

Asn Lys Phe Arg

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carbamoylpropanamido]hexanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C25H41N9O6 (563.318)


   

Asn Lys Arg Phe

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carbamoylpropanamido]hexanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C25H41N9O6 (563.318)


   

Asn Arg Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-5-carbamimidamidopentanamido]hexanamido]-3-phenylpropanoic acid

C25H41N9O6 (563.318)


   

Arg Glu Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carboxybutanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C26H41N7O7 (563.3067)


   

Arg Glu Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carboxybutanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C26H41N7O7 (563.3067)


   

Arg Glu Ile Phe

(4S)-4-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-{[(1S,2S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-methylbutyl]carbamoyl}butanoic acid

C26H41N7O7 (563.3067)


   

Arg Glu Leu Phe

(4S)-4-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-3-methylbutyl]carbamoyl}butanoic acid

C26H41N7O7 (563.3067)


   

Arg Phe Glu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-4-carboxybutanamido]-3-methylpentanoic acid

C26H41N7O7 (563.3067)


   

Arg Phe Glu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-4-carboxybutanamido]-4-methylpentanoic acid

C26H41N7O7 (563.3067)


   

Arg Phe Ile Glu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-methylpentanamido]pentanedioic acid

C26H41N7O7 (563.3067)


   

Arg Phe Lys Asn

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]hexanamido]-3-carbamoylpropanoic acid

C25H41N9O6 (563.318)


   

Arg Phe Leu Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-4-methylpentanamido]pentanedioic acid

C26H41N7O7 (563.3067)


   

Arg Phe Asn Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-carbamoylpropanamido]hexanoic acid

C25H41N9O6 (563.318)


   

Arg Ile Glu Phe

(4S)-4-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-4-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butanoic acid

C26H41N7O7 (563.3067)


   

Arg Ile Phe Glu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-phenylpropanamido]pentanedioic acid

C26H41N7O7 (563.3067)


   

Arg Lys Phe Asn

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]-3-phenylpropanamido]-3-carbamoylpropanoic acid

C25H41N9O6 (563.318)


   

Arg Lys Asn Phe

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]-3-carbamoylpropanamido]-3-phenylpropanoic acid

C25H41N9O6 (563.318)


   

Arg Leu Glu Phe

(4S)-4-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-4-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butanoic acid

C26H41N7O7 (563.3067)


   

Arg Leu Phe Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-phenylpropanamido]pentanedioic acid

C26H41N7O7 (563.3067)


   

Arg Asn Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-carbamoylpropanamido]-3-phenylpropanamido]hexanoic acid

C25H41N9O6 (563.318)


   

Arg Asn Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-carbamoylpropanamido]hexanamido]-3-phenylpropanoic acid

C25H41N9O6 (563.318)


   

Val Phe Ile Trp

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Val Phe Leu Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Val Phe Trp Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Val Phe Trp Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Val Ile Phe Trp

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Val Ile Trp Phe

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Val Leu Phe Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Val Leu Trp Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Val Trp Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Val Trp Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Val Trp Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Val Trp Leu Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Trp Phe Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-methylpentanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Trp Phe Leu Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Trp Phe Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Trp Phe Val Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-methylbutanamido]-4-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Trp Ile Phe Val

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Trp Ile Val Phe

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Trp Leu Phe Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Trp Leu Val Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Trp Val Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Trp Val Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Trp Val Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Trp Val Leu Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Dihydroergocornine

Dihydroergocornine

C31H41N5O5 (563.3108)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists Ergocornine in which a single bond replaces the double bond between positions 9 and 10. C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

   

ST 28:4;O7;Gly

ST 28:4;O7;Gly

C30H45NO9 (563.3094)


   

ST 22:3;O4;HexNAc

ST 22:3;O4;HexNAc

C30H45NO9 (563.3094)


   
   

(4s)-n-{2-hydroxy-4,7-diisopropyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0²,⁶]dodecan-4-yl}-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(15),2,12(16),13-tetraene-4-carboximidic acid

(4s)-n-{2-hydroxy-4,7-diisopropyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0²,⁶]dodecan-4-yl}-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(15),2,12(16),13-tetraene-4-carboximidic acid

C31H41N5O5 (563.3108)


   

(2s,3r,4r)-2-[(2r,4s,4as,4bs,5s,10ar,12ar)-7-amino-4,5-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,10a-dimethyl-6,9-dioxo-2,3,4,4b,5,11,12,12a-octahydro-1,10-dioxatetraphen-8-yl]-4-methylhexan-3-yl acetate

(2s,3r,4r)-2-[(2r,4s,4as,4bs,5s,10ar,12ar)-7-amino-4,5-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,10a-dimethyl-6,9-dioxo-2,3,4,4b,5,11,12,12a-octahydro-1,10-dioxatetraphen-8-yl]-4-methylhexan-3-yl acetate

C30H45NO9 (563.3094)


   

21-(acetyloxy)-14-ethyl-2-hydroxy-6,19-dimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-4-yl 2-methylpropanoate

21-(acetyloxy)-14-ethyl-2-hydroxy-6,19-dimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-4-yl 2-methylpropanoate

C30H45NO9 (563.3094)